Protective effects of GLP-1 analogues exendin-4 and GLP-1(936) amide against ischemia-reperfusion injury in rat heart
Further studies are needed to understand the biological mechanisms, if any, between GLP-1 RAs and breast cancer outcomes
Sepanjnia K, Modabbernia A, Ashrafi M, Modabbernia M-J, Akhondzadeh S
"There is a growing appreciation that the quality of weight loss is as important as the quantity of weight loss," Scott Harris, Altimmune's chief medical officer, said in a release
A formal incretin analysis in humans was published in December of 1987 from Steven Blooms laboratory [32], clearly demonstrating the incretin-like insulinotropic potential of GLP-1, which was actually greater than that of GIP studied in the same experiments